SBI Securities
FLNA icon

SBI Securities’s Filana Therapeutics FLNA Stock Holding History

SBI Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.65K Buy
2,986
+1,100
+58% +$1.04K ﹤0.01% 2476
2026
Q2 		$2.24K Buy
1,886
+655
+53% +$933 ﹤0.01% 2517
2026
Q1 		$2.08K Sell
1,231
-10
-0.8% -$21 ﹤0.01% 2411
2025
Q4 		$2.46K Sell
1,241
-208
-14% -$666 ﹤0.01% 2308
2025
Q3 		$4.22K Hold
1,449
– – ﹤0.01% 2117
2025
Q2 		$2.62K Buy
1,449
+202
+16% +$359 ﹤0.01% 2275
2025
Q1 		$1.87K Buy
1,247
+19
+2% +$48 ﹤0.01% 2317
2024
Q4 		$2.9K Buy
+1,228
New +$21.6K ﹤0.01% 2137

Other funds holding FLNA

Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities's FLNA Position: Q3 2026 in Review

SBI Securities increased its Filana Therapeutics (FLNA) stake by 58% in Q3 2026, buying an estimated $1.04K and bringing the position to 2,986 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

SBI Securities first reported a position in FLNA in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.22K in Q3 2025. 8 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

  • SBI Securities held 2,986 shares of Filana Therapeutics worth $2.65K as of Q3 2026.
  • SBI Securities bought 1,100 Filana Therapeutics shares in Q3 2026, an estimated $1.04K.
  • Filana Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2476 holding.
  • SBI Securities first reported a position in Filana Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Filana Therapeutics position peaked at $4.22K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.